H Koponen
Overview
Explore the profile of H Koponen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Somersalo A, Paloneva J, Lonnroos E, Heinanen M, Koponen H, Kiviranta I
Scand J Surg
. 2018 May;
107(4):345-349.
PMID: 29739286
Background And Aims:: The death of any young individual is associated with the loss of many potentially fulfilling years of life. It has been suggested that the relative mortality of...
2.
Hulkko A, Murray G, Moilanen J, Haapea M, Rannikko I, Jones P, et al.
Eur Psychiatry
. 2017 Jul;
45:50-58.
PMID: 28728095
Background: Higher lifetime antipsychotic exposure has been associated with poorer cognition in schizophrenia. The cognitive effects of adjunctive psychiatric medications and lifetime trends of antipsychotic use remain largely unclear. We...
3.
Molins C, Roldan A, Corripio I, Isohanni M, Miettunen J, Seppala J, et al.
Schizophr Res
. 2016 Sep;
178(1-3):64-67.
PMID: 27650195
No abstract available.
4.
Rissanen I, Jaaskelainen E, Isohanni M, Koponen H, Ansakorpi H, Miettunen J
Epilepsy Behav
. 2015 May;
46:198-204.
PMID: 25935512
Both antiepileptic drugs (AEDs) and benzodiazepines (BZDs) have previously been associated with an increased risk of suicidality. Our aim was to study the association between the use of conventional AEDs...
5.
Moilanen J, Huhtaniska S, Haapea M, Jaaskelainen E, Veijola J, Isohanni M, et al.
Eur Psychiatry
. 2015 Mar;
30(5):598-605.
PMID: 25791180
Background: In schizophrenia, brain morphometric changes may be associated with antipsychotic medication. Only limited data is available concerning individuals with schizophrenia without antipsychotic medication. We aimed to study the associations...
6.
Jyrkka J, Kautiainen H, Koponen H, Puolakka K, Virta L, Pohjolainen T, et al.
Scand J Rheumatol
. 2014 Mar;
43(5):364-70.
PMID: 24650284
Objectives: The aim of this study was to investigate antidepressant use in a nationwide cohort of persons with incident rheumatoid arthritis (RA) in 2000-2007 in Finland. Method: Register data from...
7.
Moilanen J, Haapea M, Miettunen J, Jaaskelainen E, Veijola J, Isohanni M, et al.
Eur Psychiatry
. 2011 Sep;
28(1):53-8.
PMID: 21920710
Objective: To estimate the prevalence of non-medicated subjects having schizophrenia spectrum disorder and to study how they differ from medicated subjects in terms of sociodemographic and illness-related variables. We also...
8.
Koponen H, Lepola H, Leinonen E
Eur Psychiatry
. 2009 Aug;
10(4):209-10.
PMID: 19698341
No abstract available.
9.
Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J
Acta Psychiatr Scand
. 2009 Apr;
120(2):85-96.
PMID: 19374633
Objective: Our aim was to present recent studies of alcohol use disorders (AUDs) in patients with schizophrenia, estimate overall prevalence and characteristics affecting the prevalence of AUDs. Method: We conducted...
10.
Vanhala M, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Koponen H
Acta Psychiatr Scand
. 2008 Nov;
119(2):137-42.
PMID: 19016666
Objective: To evaluate the risk for developing metabolic syndrome when having depressive symptoms. Method: The prevalence of depressive symptoms and metabolic syndrome at baseline, and after a 7-year follow-up as...